Precision Meds offers a comprehensive suite of medicines optimisation services aimed at reducing inappropriate prescribing and ensuring patient safety. Our services align with Medicines Optimisation  programme and help healthcare organisations achieve budgetary savings in line with the national Quality, Innovation, Productivity, and Prevention (QIPP) challenges.

We provide a range of Medicines optimisation programmes that can be tailored to fit the unique needs of your organisation. These programmes are designed with flexibility in mind, both in terms of delivery models and funding options. In some cases, we offer part or full sponsorship, meaning that clinical reviews and interventions can be implemented without any cost implications for your healthcare organisation.

Alternatively, we offer an invest-to-save model where the initial investment yields substantial returns. With this model, our services typically deliver a return on investment that considerably exceeds the initial cost. This approach ensures that your organisation not only improves patient care and safety but also realises significant financial benefits in the long run.

At Precision Meds, we are committed to optimising therapy, improving patient outcomes, and providing cost-effective solutions for healthcare organisations. Our services are designed to align with national initiatives, while offering flexibility and financial benefits to support your organisation's goals.